Exhibits

Exhibit and Marketing Opportunities Now Available

Ignite your brand’s visibility, create meaningful connections and network your way to success.

Join the Discussion October 16th at 3:40 PM!

Using the EHR to Identify Long COVID Patients in Near-real-time: A Feasibility Assessment of Truveta Data

Truveta Data includes full medical records for nearly 100 million patients across the United States from more than 31 health systems. As researchers race to better understand Long COVID as an emerging disease, near-real-time EHR data can be utilized to describe characteristics of this patient population, such as information on demographic factors and social drivers of health, along with differences in vaccination status prior to COVID-19 onset and post-COVID symptomology. Further, Truveta Data allows researchers to quickly explore different data definitions and algorithms for identifying patient with Long COVID as our understanding of this disease evolves.

Join the Discussion October 17th at 10:40 AM!

RWE Integration by Design: An Essential Component of Early RCT Design

Real-world data (RWD) and real-world evidence (RWE) often find their place in clinical development toward its conclusion. Results derived from them are often reserved for medical affairs, market access, or to bolster existing pre-planned clinical trials. However, this approach can create significant challenges, hindering the potential utility of RWE due to trial designs and protocols that may not align well with generating fit-for-purpose RWD. Today, there is growing momentum from regulators and scientists to shift towards a systematic integration of RWE during the initial trial design phase.

This presentation sheds light on the barriers that traditionally separate randomized clinical trials (RCTs) and RWE, highlighting the need for a more blended approach. Emerging concepts such as externally controlled trials and innovative designs like cohort multiple randomized controlled trials or trials within-cohorts are gaining traction as effective means to capture novel patient insights. By exploring the convergence of these diverse methodologies, we can uncover more meaningful and comprehensive insights than what each can achieve independently.

Exhibiting Companies

Aetion
BMJ Impact Analytics
Clinetic
Forian
MarketScan by Merative
OM1
OMNY Health
Platform Life Sciences
Target RWE
Truveta
Verantos

Have an account?

Real-World Evidence Conference

Exhibit and Marketing Opportunities Now Available

Exhibiting Companies

Be informed and stay engaged.